Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports

BACKGROUND: The Cochrane risk of bias tool is a prominent instrument used to evaluate potential biases in clinical trials. In three updates of our Cochrane review on neuraminidase inhibitors, we assessed risk of bias on the same trials using different levels of detail: the trials in journal publicat...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jefferson, Tom, Jones, Mark A, Doshi, Peter, Del Mar, Chris B, Hama, Rokuro, Thompson, Matthew J, Onakpoya, Igho, Heneghan, Carl J
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2014
Témata:
Evidence Based Practice
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4179405/
https://ncbi.nlm.nih.gov/pubmed/25270852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-005253
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky